跳至主要内容
临床试验/NL-OMON49142
NL-OMON49142已完成不适用

[68Ga]Ga-DOTA-(RGD)2 PET/CT imaging of activated endothelium in lung parenchyma of COVID-19 patients. - RDG-PET/CT imaging in COVID-19 patients.

Radboud Universitair Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * A microbiologically proven SARS-CoV-19 infection
  • * Pulmonary involvement as demonstrated on recent (<1 week) chest CT
  • * Enrolled in the BioMarCo-19 study (CMO2020-6344)
  • * More than or equal to 18 years of age;
  • * Ability to provide written informed consent.

排除标准

  • * Contra-indication for PET:
  • o Pregnancy;
  • o Breast-feeding;
  • o Severe claustrophobia.
  • * Contra-indication for administration of iodine-containing contrast agents.
  • * Other serious illness, e.g. history of malignancies
  • * Estimated creatinine clearance * 30 mL/min according to the Cockcroft-Gault
  • formula (or local institutional standard method)

研究者

相似试验

[68Ga]Ga-DOTA-(RGD)2 PET/CT imaging of activated... | 临床试验